<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Epidemiology and pathogenesis of obesity hypoventilation syndrome</title><link href="/z/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/z/d/css/icofont.min.css" rel="stylesheet"/><link href="/z/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/z/d/css/animate.css" rel="stylesheet"/><link href="/z/d/css/owl.carousel.css" rel="stylesheet"/><link href="/z/d/css/magnific-popup.css" rel="stylesheet"/><link href="/z/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/z/d/css/style.css" rel="stylesheet"/><link href="/z/d/css/rtl_edited.css" rel="stylesheet"/><link href="/z/d/css/responsive.css" rel="stylesheet"/><link href="https:///uptodate_assets/main.css" rel="stylesheet"/>
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>
<meta content="" name="description"/>
<link href="/z/d/img/favicon.png" rel="icon" type="image/png">
</link></head>
<body>
<!-- Start Main Menu Area -->
<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>
<section class="teacher-area ptb-10">
<div class="container">
</div>
<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Epidemiology and pathogenesis of obesity hypoventilation syndrome</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Epidemiology and pathogenesis of obesity hypoventilation syndrome</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Authors:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Amanda Piper, PhD</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Brendon Yee, MBChB, PhD</a></dd><dt><span> </span>Section Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">M Safwan Badr, MD</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Geraldine Finlay, MD</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Jun 16, 2023.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H1637744"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>Obesity Hypoventilation Syndrome (OHS; "Pickwickian syndrome") is defined as the presence of <strong>awake</strong> alveolar hypoventilation (arterial carbon dioxide tension [PaCO<sub>2</sub>] &gt;45 mmHg) in an obese individual (body mass index ≥30 kg/m<sup>2</sup>) which cannot be attributed to other conditions associated with alveolar hypoventilation (eg, neuromuscular disorders) [<a href="#rid1">1-3</a>].</p><p>The pathogenesis of OHS is reviewed here. Clinical manifestations, diagnosis, and treatment are discussed separately. (See  <a class="medical medical_review" href="/z/d/html/7698.html" rel="external">"Clinical manifestations and diagnosis of obesity hypoventilation syndrome"</a> and  <a class="medical medical_review" href="/z/d/html/7713.html" rel="external">"Treatment and prognosis of the obesity hypoventilation syndrome"</a> and  <a class="medical medical_review" href="/z/d/html/7714.html" rel="external">"Noninvasive positive airway pressure therapy for the obesity hypoventilation syndrome"</a>.)</p><p class="headingAnchor" id="H1362161206"><span class="h1">EPIDEMIOLOGY</span><span class="headingEndMark"> — </span>Prevalence estimates for OHS are inaccurate and vary significantly due to differences in disease definition, population studied, and methods of sample acquisition.</p><p class="bulletIndent1"><span class="glyph">●</span>General population – Estimates based on rates of obesity and obstructive sleep apnea (OSA) in the community suggest 0.15 to 0.3 percent of the adult population in the United States are likely to have OHS [<a href="#rid1">1</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Obese population – The prevalence of OHS increases as body mass index (BMI) rises [<a href="#rid4">4,5</a>]. In several retrospective studies among patients with OSA, the prevalence of OHS in those with a BMI of 30 to 35 kg/m<sup>2</sup> is 8 to 12 percent, higher among those with a BMI ≥40 kg/m<sup>2</sup> (18 to 31 percent) and those with a BMI ≥50 kg/m<sup>2</sup> (50 percent) [<a href="#rid1">1,5-9</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>OSA – Retrospective studies report a rate of 16 percent among those referred to sleep center with symptoms of OSA, higher (22 percent) if patients were obese, or have severe OSA (eg, apnea hypopnea index &gt;60 events per hour; 20 to 30 percent) [<a href="#rid5">5,6,10</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Bariatric surgery – Prevalence rates vary from 8 to 65 percent in bariatric surgical patients [<a href="#rid11">11-13</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Hospitalized patients – In a study of hospitalized patients with a BMI &gt;35 kg/m<sup>2</sup>, the prevalence of OHS was 31 percent [<a href="#rid4">4</a>]. In a single center study, 8 percent of ICU admissions fulfilled the criteria for OHS [<a href="#rid14">14</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Chronic hypoxemia – In another study of patients with obesity with chronic hypoxemia, 51 percent were found to have OHS [<a href="#rid15">15</a>].</p><p></p><p>Ethnic factors also affect prevalence rates. In Japanese patients presenting for investigation of OSA, 2.3 percent were found to have OHS [<a href="#rid16">16</a>] compared with 20 percent of predominantly African-American patients evaluated at a United States sleep center [<a href="#rid6">6</a>]. However, Asian-Americans may develop OHS at a lower BMI than non-Asian Americans, possibly due to cephalometric differences [<a href="#rid7">7,16-19</a>].</p><p class="headingAnchor" id="H1637750"><span class="h1">PATHOGENESIS</span><span class="headingEndMark"> — </span>Obesity (body mass index [BMI] &gt;30 kg/m<sup>2</sup>), in particular, severe obesity (BMI &gt;50 kg/m<sup>2</sup>), is the major risk factor for OHS [<a href="#rid1">1,5-9,20</a>]. Obesity induces increased demand on the respiratory system that triggers compensatory mechanisms to maintain adequate ventilation (ie, eucapnia; partial arterial pressure of carbon dioxide [PaCO<sub>2</sub> &lt;45 mmHg]). It is thought that OHS develops due to the failure of such compensatory mechanisms resulting in hypoventilation and hypercapnia (PaCO<sub>2</sub> ≥45 mmHg) [<a href="#rid21">21</a>].</p><p>A complex interaction between the following factors is likely involved in the pathogenesis of OHS  (<a class="graphic graphic_table graphicRef94511" href="/z/d/graphic/94511.html" rel="external">table 1</a> and <a class="graphic graphic_algorithm graphicRef94512" href="/z/d/graphic/94512.html" rel="external">algorithm 1</a>) [<a href="#rid21">21</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>Sleep disordered breathing (SDB)</p><p class="bulletIndent1"><span class="glyph">●</span>Altered pulmonary mechanics</p><p class="bulletIndent1"><span class="glyph">●</span>Impaired ventilatory control</p><p class="bulletIndent1"><span class="glyph">●</span>Increased carbon dioxide production</p><p></p><p>A "pre-OHS" state in patients with class 2 or 3 obesity who have a normal daytime PaCO<sub>2</sub> but an elevated base excess or bicarbonate has been proposed [<a href="#rid22">22</a>]. A European Respiratory Taskforce addressing diagnostic and therapeutic standards in central sleep breathing disturbances has put forward a framework for defining obesity-related hypoventilation, which incorporates this concept [<a href="#rid2">2</a>]. In this framework:</p><p class="bulletIndent1"><span class="glyph">●</span>Stages I and II obesity-related hypoventilation incorporates obese individuals with intermittent sleep hypercapnia but a normal awake PaCO<sub>2.</sub> Serum bicarbonate in these stages are &lt;27 mmol/L or &gt;27 mmol/L, respectively.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Stages III and IV describe OHS individuals, with Stage IV representing those OHS individuals with cardiometabolic comorbidities while Stage III OHS do not.</p><p></p><p>Further studies are needed to understand the processes that influence progression of obesity to OHS.</p><p class="headingAnchor" id="H1637768"><span class="h2">Sleep disordered breathing</span><span class="headingEndMark"> — </span>The role of SDB in the pathogenesis of OHS is supported by the following observations:</p><p class="bulletIndent1"><span class="glyph">●</span>The majority of patients with OHS have concurrent obstructive sleep apnea (OSA) while pure sleep hypoventilation alone (nonobstructive events) is present in around 10 percent of individuals [<a href="#rid7">7,23-25</a>]. Ninety percent of patients with OHS have at least mild OSA (apnea-hypopnea index [AHI] &gt;5 events per hour), with severe disease (AHI &gt;30 events per hour) seen in 70 percent [<a href="#rid26">26</a>]. Most studies have examined mechanisms at play in patients with OHS and OSA and it is presumed that the same mechanisms are likely contributing in those with OHS and sleep hypoventilation. (See  <a class="medical medical_review" href="/z/d/html/7706.html" rel="external">"Clinical presentation and diagnosis of obstructive sleep apnea in adults"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Treatment of the nocturnal SDB usually with positive airway pressure or rarely tracheostomy, also treats/eliminates OHS [<a href="#rid17">17,27-29</a>]. (See  <a class="medical medical_review" href="/z/d/html/7695.html" rel="external">"Obstructive sleep apnea: Overview of management in adults"</a>.)</p><p></p><p>In addition, although other obesity-related mechanisms (eg, altered mechanics and impaired ventilatory control) play a role in promoting hypoventilation during wakefulness, changes in gas exchange are most prominent during sleep, further emphasizing the contribution of SDB to the pathogenesis of OHS.</p><p class="headingAnchor" id="H3603737937"><span class="h3">Reduced nocturnal carbon dioxide clearance</span><span class="headingEndMark"> — </span>The mechanism of reduced nocturnal carbon dioxide (CO<sub>2</sub>) clearance is best studied in patients with OSA [<a href="#rid30">30-35</a>]. During obstructive apneic or hypopneic events, the partial arterial pressure of carbon dioxide (PaCO<sub>2</sub>) rises  (<a class="graphic graphic_figure graphicRef94513" href="/z/d/graphic/94513.html" rel="external">figure 1</a>). Patients with OSA who do not have OHS (ie, eucapnic OSA) are able to normalize their PaCO<sub>2</sub> between such respiratory events. In contrast, OHS patients with OSA have reduced ventilation for longer periods between events, so that CO<sub>2</sub> is not adequately eliminated (ie, hypercapnic acidosis develops) [<a href="#rid30">30,31</a>]. The renal system responds by retaining bicarbonate to buffer the falling pH [<a href="#rid32">32,33</a>]. If the renal system cannot adequately excrete the retained bicarbonate before the next sleep period, a gradual accumulation of serum bicarbonate occurs [<a href="#rid33">33</a>]. Raised serum bicarbonate levels will blunt the ventilatory response to additional rises in CO<sub>2</sub> (ie, "won't breathe"), and ultimately results in the development of chronic alveolar hypoventilation as evidenced by a compensated respiratory acidosis during awake periods [<a href="#rid34">34</a>].</p><p class="headingAnchor" id="H817611470"><span class="h3">Nocturnal hypoxemia</span><span class="headingEndMark"> — </span>In addition to awake and sleep hypercapnia, individuals with OHS exhibit more severe nocturnal hypoxemia during sleep than those with eucapnic OSA and/or obesity. The percentage of total sleep time spent with peripheral oxygen saturation levels &lt;90 percent is strongly associated with the development of awake hypercapnia [<a href="#rid20">20</a>]. Sustained hypoxemia during external resistive loading in healthy individuals (which "mimics" obesity) was shown to result in delayed arousal during sleep [<a href="#rid36">36</a>], thereby promoting more prolonged periods of abnormal breathing. (See  <a class="medical medical_review" href="/z/d/html/101436.html" rel="external">"Mechanisms, causes, and effects of hypercapnia", section on 'Oxygen-induced hypercapnia'</a>.)</p><p class="headingAnchor" id="H4909169"><span class="h2">Impaired pulmonary mechanics</span></p><p class="headingAnchor" id="H4909175"><span class="h3">Abnormal spirometry</span><span class="headingEndMark"> — </span>In patients with class 2 or 3 obesity, fat accumulation around the abdomen and chest wall contributes to a restrictive deficit which can impair ventilation. The inertial load of obesity itself and effect of gravity may further contribute to impaired alveolar ventilation, particularly during sleep [<a href="#rid37">37-39</a>]. Pulmonary function test findings in obesity are discussed separately. (See  <a class="medical medical_review" href="/z/d/html/7698.html" rel="external">"Clinical manifestations and diagnosis of obesity hypoventilation syndrome", section on 'Pulmonary function tests'</a>.)</p><p class="headingAnchor" id="H4909181"><span class="h3">Ventilation/perfusion mismatching</span><span class="headingEndMark"> — </span>Ventilation/perfusion (V/Q) mismatching in obese individuals may contribute to CO<sub>2</sub> accumulation and hypoxemia in patients with OHS.</p><p class="bulletIndent1"><span class="glyph">●</span>Individuals with OHS adopt a pattern of breathing characterized by low tidal volume and increased respiratory rate, which increases anatomic dead space leading to CO<sub>2</sub> accumulation [<a href="#rid40">40</a>]. (See  <a class="medical medical_review" href="/z/d/html/101436.html" rel="external">"Mechanisms, causes, and effects of hypercapnia", section on 'Increased dead space'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Obese individuals poorly ventilate (V) the lower lobes of their lungs, which may be due to diminished lung compliance, difficulty moving the ribcage and diaphragm, and closure of some alveoli prior to the end of expiration [<a href="#rid41">41</a>]. Obese individuals also have increased lower lobe perfusion (Q) due to increased pulmonary blood volume. The resulting V/Q mismatching (ie, areas that are underventilated relative to perfusion), leads to hypoxemia which can contribute to OHS. (See  <a class="medical medical_review" href="/z/d/html/1647.html" rel="external">"Measures of oxygenation and mechanisms of hypoxemia"</a>.)</p><p></p><p class="headingAnchor" id="H4909187"><span class="h3">Reduced respiratory muscle strength</span><span class="headingEndMark"> — </span>Obesity is associated with an increased work of breathing due to the increased load of obesity itself, a process that is exaggerated in the supine position during sleep [<a href="#rid42">42</a>]. Thus, respiratory muscles (eg, diaphragm and intercostal muscles) need to work harder to maintain eucapnia. Reduced respiratory muscle strength may contribute to the pathogenesis of OHS by contributing to hypoventilation (ie, "can't breathe"):</p><p class="bulletIndent1"><span class="glyph">●</span>Patients with OHS often have a modest reduction in respiratory muscle strength and endurance, which worsens in the supine position [<a href="#rid42">42,43</a>]. Although respiratory muscle impairment generally needs to be severe to cause clinically significant hypoventilation, modest impairment may be sufficient when other contributing factors such as excessive abdominal obesity, severe upper airway obstruction or low insulin-like growth factor 1 are present [<a href="#rid44">44</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Maximum voluntary ventilation (MVV), a marker of respiratory muscle strength, has been shown to be lower in patients with OHS compared with patients who have obesity but do not have OHS and negatively correlates with CO<sub>2</sub> levels [<a href="#rid38">38</a>]. (See  <a class="medical medical_review" href="/z/d/html/101436.html" rel="external">"Mechanisms, causes, and effects of hypercapnia", section on 'Decreased minute ventilation/global hypoventilation'</a>.)</p><p></p><p class="headingAnchor" id="H1637774"><span class="h2">Impaired ventilatory control</span></p><p class="headingAnchor" id="H79804216"><span class="h3">Reduced neural drive</span><span class="headingEndMark"> — </span>Neural drive is two to three times greater in patients with class 2 or 3 obesity without OHS compared to those of normal weight [<a href="#rid42">42,45</a>]. However, individuals with OHS lack this augmented drive [<a href="#rid46">46-48</a>].</p><p class="headingAnchor" id="H1121418072"><span class="h3">Reduced ventilatory responsiveness</span><span class="headingEndMark"> — </span>Hypoxemic and hypercapnic ventilatory responses (ie, the stimulation of ventilation by hypoxemia and hypercapnia) are typically reduced during sleep and may be exaggerated in patients with OHS, especially when patients are supine [<a href="#rid22">22,39,44,49-51</a>]. While the diminished ventilatory responsiveness to hypoxemia and hypercapnia appears to be an acquired, rather than a primary, defect, some evidence suggests that a reduced hypoxic ventilatory response exists in patients with obesity prior to the onset of overt OHS, thus some predisposition may exist [<a href="#rid22">22</a>]. In addition, studies show improved ventilatory responsiveness following effective treatment of sleep disordered breathing [<a href="#rid49">49,52</a>].</p><p class="headingAnchor" id="H4908593"><span class="h3">Leptin resistance</span><span class="headingEndMark"> — </span>Leptin is an adipokine produced in adipose tissue that stimulates ventilation [<a href="#rid53">53</a>]. Leptin resistance has been proposed as one mechanism that contributes to OHS.</p><p class="bulletIndent1"><span class="glyph">●</span>Pre-clinical animal studies – Genetically obese leptin-deficient mice demonstrate many of the characteristics of human OHS including impaired respiratory mechanics, depressed ventilatory responsiveness to CO<sub>2</sub> and awake hypoventilation [<a href="#rid54">54</a>]. Leptin replacement improved the sensitivity to CO<sub>2</sub> and resulted in increased minute ventilation [<a href="#rid55">55</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>A study has shown acute intranasal leptin in diet-induced obese mice reduced oxygen desaturation events in rapid eye movement (REM) sleep and increased ventilation in non-REM and REM sleep. Chronic intranasal leptin decreased food intake and body weight [<a href="#rid56">56</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Human studies – Elevated serum leptin levels have been reported in patients with obesity, particularly those with OHS [<a href="#rid57">57,58</a>]. In one study obese hypercapnic patients had higher serum leptin levels than eucapnic patients (39 versus 21 ng/mL) and serum leptin predicted the presence of hypercapnia [<a href="#rid57">57</a>]. It was hypothesized that the increased leptin levels may be a compensatory response to leptin resistance and/or an effort to maintain alveolar ventilation in the setting of a high ventilatory load due to obesity and increased upper airway resistance [<a href="#rid57">57</a>]. Another study reported higher leptin levels in patients with OHS compared with eucapnic patients with OSA of the same degree [<a href="#rid58">58</a>].</p><p></p><p class="bulletIndent1">Studies that examine the impact of noninvasive positive airway pressure therapy on leptin levels are conflicting. One study of OHS patients reported that compared with those who were noncompliant with noninvasive ventilation (NIV), those who were compliant experienced a reduction in leptin levels [<a href="#rid59">59</a>]. In contrast, a trial of 35 patients with OHS reported that compared with lifestyle modifications, NIV did not reduce leptin levels, despite improvements in sleep and daytime gas exchange [<a href="#rid60">60</a>]. Finally, in a study of six patients with OHS (sleep hypoventilation but without OSA) leptin levels increased after treatment with NIV; the increase correlated with the degree of improvement in the ventilatory sensitivity to CO<sub>2</sub> [<a href="#rid61">61</a>].</p><p></p><p class="headingAnchor" id="H3244363575"><span class="h2">Carbon dioxide overproduction</span><span class="headingEndMark"> — </span>Excess CO<sub>2</sub> production is associated with increased body surface area [<a href="#rid62">62</a>]. This was supported by a study that compared patients with OSA and OHS with patients who had OSA at the same severity [<a href="#rid62">62</a>]. Higher PaCO<sub>2</sub>, lower PaO<sub>2</sub>, and greater CO<sub>2</sub> production were found in those with OHS without any differences in indices of alveolar ventilation (eg, minute ventilation, dead space). Excess CO<sub>2</sub> production is also supported by the observation that weight loss alone decreases PaCO<sub>2</sub> during wakefulness in patients with OHS  (<a class="graphic graphic_figure graphicRef80196" href="/z/d/graphic/80196.html" rel="external">figure 2</a>) [<a href="#rid63">63</a>]. (See  <a class="medical medical_review" href="/z/d/html/101436.html" rel="external">"Mechanisms, causes, and effects of hypercapnia", section on 'Increased production of carbon dioxide'</a>.)</p><p class="headingAnchor" id="H1637780"><span class="h1">SUMMARY AND RECOMMENDATIONS</span></p><p class="bulletIndent1"><span class="glyph">●</span>Obesity hypoventilation syndrome (OHS) is defined as the presence of <strong>awake</strong> alveolar hypoventilation (arterial carbon dioxide tension [PaCO<sub>2</sub>] &gt;45 mmHg) in an obese individual (body mass index [BMI] ≥30 kg/m<sup>2</sup>) which cannot be attributed to other conditions associated with alveolar hypoventilation (eg, neuromuscular disorders). (See <a class="local">'Introduction'</a> above and  <a class="medical medical_review" href="/z/d/html/7698.html" rel="external">"Clinical manifestations and diagnosis of obesity hypoventilation syndrome"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>OHS is uncommon in the general population but is more prevalent in patients with obesity and patients with obstructive sleep apnea (OSA). (See <a class="local">'Epidemiology'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Alveolar hypoventilation in patients with obesity occurs when the normal compensatory ventilatory mechanisms that maintain adequate ventilation fail. OHS is likely due to a complex interaction of several physiologic abnormalities, including sleep disordered breathing (obstructive sleep apnea and/or sleep hypoventilation), altered pulmonary mechanics (restriction, ventilation/perfusion mismatching, reduced respiratory muscle strength), altered ventilatory control (reduced neural drive and ventilatory responsiveness, leptin resistance), and increased carbon dioxide production. (See <a class="local">'Pathogenesis'</a> above.)</p><p></p><p class="headingAnchor" id="H1638735"><span class="h1">ACKNOWLEDGMENT</span><span class="headingEndMark"> — </span>The UpToDate editorial staff acknowledges Paul Suratt, MD, who contributed to earlier versions of this topic review.</p></div><div class="headingAnchor" id="references"><ol id="reference"><li><a class="nounderline abstract_t">Mokhlesi B. Obesity hypoventilation syndrome: a state-of-the-art review. Respir Care 2010; 55:1347.</a></li><li><a class="nounderline abstract_t">Randerath W, Verbraecken J, Andreas S, et al. Definition, discrimination, diagnosis and treatment of central breathing disturbances during sleep. Eur Respir J 2017; 49.</a></li><li><a class="nounderline abstract_t">Sleep-related breathing disorders in adults: recommendations for syndrome definition and measurement techniques in clinical research. The Report of an American Academy of Sleep Medicine Task Force. Sleep 1999; 22:667.</a></li><li><a class="nounderline abstract_t">Nowbar S, Burkart KM, Gonzales R, et al. Obesity-associated hypoventilation in hospitalized patients: prevalence, effects, and outcome. Am J Med 2004; 116:1.</a></li><li><a class="nounderline abstract_t">Macavei VM, Spurling KJ, Loft J, Makker HK. Diagnostic predictors of obesity-hypoventilation syndrome in patients suspected of having sleep disordered breathing. J Clin Sleep Med 2013; 9:879.</a></li><li><a class="nounderline abstract_t">Mokhlesi B, Tulaimat A, Faibussowitsch I, et al. Obesity hypoventilation syndrome: prevalence and predictors in patients with obstructive sleep apnea. Sleep Breath 2007; 11:117.</a></li><li><a class="nounderline abstract_t">Kessler R, Chaouat A, Schinkewitch P, et al. The obesity-hypoventilation syndrome revisited: a prospective study of 34 consecutive cases. Chest 2001; 120:369.</a></li><li><a class="nounderline abstract_t">Banerjee D, Yee BJ, Piper AJ, et al. Obesity hypoventilation syndrome: hypoxemia during continuous positive airway pressure. Chest 2007; 131:1678.</a></li><li><a class="nounderline abstract_t">Laaban JP, Chailleux E. Daytime hypercapnia in adult patients with obstructive sleep apnea syndrome in France, before initiating nocturnal nasal continuous positive airway pressure therapy. Chest 2005; 127:710.</a></li><li><a class="nounderline abstract_t">Chau EH, Lam D, Wong J, et al. Obesity hypoventilation syndrome: a review of epidemiology, pathophysiology, and perioperative considerations. Anesthesiology 2012; 117:188.</a></li><li><a class="nounderline abstract_t">Sugerman HJ, Fairman RP, Baron PL, Kwentus JA. Gastric surgery for respiratory insufficiency of obesity. Chest 1986; 90:81.</a></li><li><a class="nounderline abstract_t">Domínguez-Cherit G, Gonzalez R, Borunda D, et al. Anesthesia for morbidly obese patients. World J Surg 1998; 22:969.</a></li><li><a class="nounderline abstract_t">Lecube A, Sampol G, Lloberes P, et al. Asymptomatic sleep-disordered breathing in premenopausal women awaiting bariatric surgery. Obes Surg 2010; 20:454.</a></li><li><a class="nounderline abstract_t">Marik PE, Desai H. Characteristics of patients with the "malignant obesity hypoventilation syndrome" admitted to an ICU. J Intensive Care Med 2013; 28:124.</a></li><li><a class="nounderline abstract_t">Povitz M, James MT, Pendharkar SR, et al. Prevalence of Sleep-disordered Breathing in Obese Patients with Chronic Hypoxemia. A Cross-Sectional Study. Ann Am Thorac Soc 2015; 12:921.</a></li><li><a class="nounderline abstract_t">Harada Y, Chihara Y, Azuma M, et al. Obesity hypoventilation syndrome in Japan and independent determinants of arterial carbon dioxide levels. Respirology 2014; 19:1233.</a></li><li><a class="nounderline abstract_t">Kawata N, Tatsumi K, Terada J, et al. Daytime hypercapnia in obstructive sleep apnea syndrome. Chest 2007; 132:1832.</a></li><li><a class="nounderline abstract_t">Akashiba T, Kawahara S, Kosaka N, et al. Determinants of chronic hypercapnia in Japanese men with obstructive sleep apnea syndrome. Chest 2002; 121:415.</a></li><li><a class="nounderline abstract_t">Akashiba T, Akahoshi T, Kawahara S, et al. Clinical characteristics of obesity-hypoventilation syndrome in Japan: a multi-center study. Intern Med 2006; 45:1121.</a></li><li><a class="nounderline abstract_t">Kaw R, Hernandez AV, Walker E, et al. Determinants of hypercapnia in obese patients with obstructive sleep apnea: a systematic review and metaanalysis of cohort studies. Chest 2009; 136:787.</a></li><li><a class="nounderline abstract_t">Piper AJ. Obesity hypoventilation syndrome--the big and the breathless. Sleep Med Rev 2011; 15:79.</a></li><li><a class="nounderline abstract_t">Manuel AR, Hart N, Stradling JR. Is a raised bicarbonate, without hypercapnia, part of the physiologic spectrum of obesity-related hypoventilation? Chest 2015; 147:362.</a></li><li><a class="nounderline abstract_t">Olson AL, Zwillich C. The obesity hypoventilation syndrome. Am J Med 2005; 118:948.</a></li><li><a class="nounderline abstract_t">Berger KI, Ayappa I, Chatr-Amontri B, et al. Obesity hypoventilation syndrome as a spectrum of respiratory disturbances during sleep. Chest 2001; 120:1231.</a></li><li><a class="nounderline abstract_t">Pérez de Llano LA, Golpe R, Ortiz Piquer M, et al. Short-term and long-term effects of nasal intermittent positive pressure ventilation in patients with obesity-hypoventilation syndrome. Chest 2005; 128:587.</a></li><li><a class="nounderline abstract_t">Masa JF, Corral J, Alonso ML, et al. Efficacy of Different Treatment Alternatives for Obesity Hypoventilation Syndrome. Pickwick Study. Am J Respir Crit Care Med 2015; 192:86.</a></li><li><a class="nounderline abstract_t">Rapoport DM, Garay SM, Epstein H, Goldring RM. Hypercapnia in the obstructive sleep apnea syndrome. A reevaluation of the "Pickwickian syndrome". Chest 1986; 89:627.</a></li><li><a class="nounderline abstract_t">Piper AJ, Wang D, Yee BJ, et al. Randomised trial of CPAP vs bilevel support in the treatment of obesity hypoventilation syndrome without severe nocturnal desaturation. Thorax 2008; 63:395.</a></li><li><a class="nounderline abstract_t">Ojeda Castillejo E, de Lucas Ramos P, Resano Barrios P, et al. Mortality in obesity-hypoventilation syndrome and prognostic risk factors. Arch Bronconeumol 2015; 51:304.</a></li><li><a class="nounderline abstract_t">Berger KI, Ayappa I, Sorkin IB, et al. Postevent ventilation as a function of CO(2) load during respiratory events in obstructive sleep apnea. J Appl Physiol (1985) 2002; 93:917.</a></li><li><a class="nounderline abstract_t">Ayappa I, Berger KI, Norman RG, et al. Hypercapnia and ventilatory periodicity in obstructive sleep apnea syndrome. Am J Respir Crit Care Med 2002; 166:1112.</a></li><li><a class="nounderline abstract_t">Norman RG, Goldring RM, Clain JM, et al. Transition from acute to chronic hypercapnia in patients with periodic breathing: predictions from a computer model. J Appl Physiol (1985) 2006; 100:1733.</a></li><li><a class="nounderline abstract_t">Berger KI, Goldring RM, Rapoport DM. Obesity hypoventilation syndrome. Semin Respir Crit Care Med 2009; 30:253.</a></li><li><a class="nounderline abstract_t">Goldring RM, Turino GM, Heinemann HO. Respiratory-renal adjustments in chronic hypercapnia in man. Extracellular bicarbonate concentration and the regulation of ventilation. Am J Med 1971; 51:772.</a></li><li><a class="nounderline abstract_t">Berger KI, Ayappa I, Sorkin IB, et al. CO(2) homeostasis during periodic breathing in obstructive sleep apnea. J Appl Physiol (1985) 2000; 88:257.</a></li><li><a class="nounderline abstract_t">Hlavac MC, Catcheside PG, McDonald R, et al. Hypoxia impairs the arousal response to external resistive loading and airway occlusion during sleep. Sleep 2006; 29:624.</a></li><li><a class="nounderline abstract_t">Resta O, Foschino-Barbaro MP, Bonfitto P, et al. Prevalence and mechanisms of diurnal hypercapnia in a sample of morbidly obese subjects with obstructive sleep apnoea. Respir Med 2000; 94:240.</a></li><li><a class="nounderline abstract_t">Javaheri S, Colangelo G, Lacey W, Gartside PS. Chronic hypercapnia in obstructive sleep apnea-hypopnea syndrome. Sleep 1994; 17:416.</a></li><li><a class="nounderline abstract_t">Lin CK, Lin CC. Work of breathing and respiratory drive in obesity. Respirology 2012; 17:402.</a></li><li><a class="nounderline abstract_t">Pankow W, Hijjeh N, Schüttler F, et al. Influence of noninvasive positive pressure ventilation on inspiratory muscle activity in obese subjects. Eur Respir J 1997; 10:2847.</a></li><li class="breakAll">Rochester DF, Arora NS. Respiratory failure from obesity. In: Medical Complications of obesity, Mancini M, Lewis B, Contaldo F (Eds), Academic Press, London 1980. p.183.</li><li><a class="nounderline abstract_t">Lee MY, Lin CC, Shen SY, et al. Work of breathing in eucapnic and hypercapnic sleep apnea syndrome. Respiration 2009; 77:146.</a></li><li><a class="nounderline abstract_t">Sharp JT, Druz WS, Kondragunta VR. Diaphragmatic responses to body position changes in obese patients with obstructive sleep apnea. Am Rev Respir Dis 1986; 133:32.</a></li><li><a class="nounderline abstract_t">Monneret D, Borel JC, Pepin JL, et al. Pleiotropic role of IGF-I in obesity hypoventilation syndrome. Growth Horm IGF Res 2010; 20:127.</a></li><li class="breakAll">Steier J, Jolley CJ, Seymour J, Roughton M, Polkey MI, Moxham J. Neural respiratory drive in obesity. Thorax. 2009 Aug;64(8):719-25.</li><li><a class="nounderline abstract_t">Lopata M, Onal E. Mass loading, sleep apnea, and the pathogenesis of obesity hypoventilation. Am Rev Respir Dis 1982; 126:640.</a></li><li><a class="nounderline abstract_t">Budweiser S, Jörres RA, Criée CP, et al. Prognostic value of mouth occlusion pressure in patients with chronic ventilatory failure. Respir Med 2007; 101:2343.</a></li><li><a class="nounderline abstract_t">Manuel AR, Hart N, Stradling JR. Correlates of obesity-related chronic ventilatory failure. BMJ Open Respir Res 2016; 3:e000110.</a></li><li><a class="nounderline abstract_t">Chouri-Pontarollo N, Borel JC, Tamisier R, et al. Impaired objective daytime vigilance in obesity-hypoventilation syndrome: impact of noninvasive ventilation. Chest 2007; 131:148.</a></li><li><a class="nounderline abstract_t">Zwillich CW, Sutton FD, Pierson DJ, et al. Decreased hypoxic ventilatory drive in the obesity-hypoventilation syndrome. Am J Med 1975; 59:343.</a></li><li class="breakAll">Jokic R, Zintel T, Sridhar G, et al. Ventilatory responses to hypercapnia and hypoxia in relatives of patients with the obesity hypoventilation syndrome. Thorax. 2000 Nov;55(11):940-5.</li><li class="breakAll">Han F, Chen E, Wei H, et al. Treatment effects on carbon dioxide retention in patients with obstructive sleep apnea-hypopnea syndrome. Chest. 2001 June 1, 2001;119(6):1814-9.</li><li><a class="nounderline abstract_t">Kalra SP. Central leptin insufficiency syndrome: an interactive etiology for obesity, metabolic and neural diseases and for designing new therapeutic interventions. Peptides 2008; 29:127.</a></li><li><a class="nounderline abstract_t">Tankersley CG, O'Donnell C, Daood MJ, et al. Leptin attenuates respiratory complications associated with the obese phenotype. J Appl Physiol (1985) 1998; 85:2261.</a></li><li class="breakAll">O'Donnell CP, Schaub CD, Haines AS, et al. Leptin prevents respiratory depression in obesity. Am J Respir Crit Care Med. 1999 May;159:1477-84.</li><li><a class="nounderline abstract_t">Berger S, Pho H, Fleury-Curado T, et al. Intranasal Leptin Relieves Sleep-disordered Breathing in Mice with Diet-induced Obesity. Am J Respir Crit Care Med 2019; 199:773.</a></li><li><a class="nounderline abstract_t">Phipps PR, Starritt E, Caterson I, Grunstein RR. Association of serum leptin with hypoventilation in human obesity. Thorax 2002; 57:75.</a></li><li><a class="nounderline abstract_t">Campo A, Frühbeck G, Zulueta JJ, et al. Hyperleptinaemia, respiratory drive and hypercapnic response in obese patients. Eur Respir J 2007; 30:223.</a></li><li><a class="nounderline abstract_t">Yee BJ, Cheung J, Phipps P, et al. Treatment of obesity hypoventilation syndrome and serum leptin. Respiration 2006; 73:209.</a></li><li><a class="nounderline abstract_t">Borel JC, Tamisier R, Gonzalez-Bermejo J, et al. Noninvasive ventilation in mild obesity hypoventilation syndrome: a randomized controlled trial. Chest 2012; 141:692.</a></li><li><a class="nounderline abstract_t">Redolfi S, Corda L, La Piana G, et al. Long-term non-invasive ventilation increases chemosensitivity and leptin in obesity-hypoventilation syndrome. Respir Med 2007; 101:1191.</a></li><li><a class="nounderline abstract_t">Javaheri S, Simbartl LA. Respiratory determinants of diurnal hypercapnia in obesity hypoventilation syndrome. What does weight have to do with it? Ann Am Thorac Soc 2014; 11:945.</a></li><li><a class="nounderline abstract_t">Rochester DF, Enson Y. Current concepts in the pathogenesis of the obesity-hypoventilation syndrome. Mechanical and circulatory factors. Am J Med 1974; 57:402.</a></li></ol></div><div id="topicVersionRevision">Topic 7697 Version 29.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20875161" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : Obesity hypoventilation syndrome: a state-of-the-art review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27920092" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : Definition, discrimination, diagnosis and treatment of central breathing disturbances during sleep.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10450601" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : Sleep-related breathing disorders in adults: recommendations for syndrome definition and measurement techniques in clinical research. The Report of an American Academy of Sleep Medicine Task Force.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14706658" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : Obesity-associated hypoventilation in hospitalized patients: prevalence, effects, and outcome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23997700" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : Diagnostic predictors of obesity-hypoventilation syndrome in patients suspected of having sleep disordered breathing.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17187265" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : Obesity hypoventilation syndrome: prevalence and predictors in patients with obstructive sleep apnea.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11502631" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : The obesity-hypoventilation syndrome revisited: a prospective study of 34 consecutive cases.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17565018" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : Obesity hypoventilation syndrome: hypoxemia during continuous positive airway pressure.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15764748" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : Daytime hypercapnia in adult patients with obstructive sleep apnea syndrome in France, before initiating nocturnal nasal continuous positive airway pressure therapy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22614131" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : Obesity hypoventilation syndrome: a review of epidemiology, pathophysiology, and perioperative considerations.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3720390" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : Gastric surgery for respiratory insufficiency of obesity.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9717423" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : Anesthesia for morbidly obese patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20020222" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : Asymptomatic sleep-disordered breathing in premenopausal women awaiting bariatric surgery.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22564878" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : Characteristics of patients with the "malignant obesity hypoventilation syndrome" admitted to an ICU.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25822569" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : Prevalence of Sleep-disordered Breathing in Obese Patients with Chronic Hypoxemia. A Cross-Sectional Study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25208458" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : Obesity hypoventilation syndrome in Japan and independent determinants of arterial carbon dioxide levels.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18079218" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : Daytime hypercapnia in obstructive sleep apnea syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11834651" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : Determinants of chronic hypercapnia in Japanese men with obstructive sleep apnea syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17106154" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : Clinical characteristics of obesity-hypoventilation syndrome in Japan: a multi-center study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19567489" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : Determinants of hypercapnia in obese patients with obstructive sleep apnea: a systematic review and metaanalysis of cohort studies.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20609602" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : Obesity hypoventilation syndrome--the big and the breathless.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25080050" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : Is a raised bicarbonate, without hypercapnia, part of the physiologic spectrum of obesity-related hypoventilation?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16164877" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : The obesity hypoventilation syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11591566" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : Obesity hypoventilation syndrome as a spectrum of respiratory disturbances during sleep.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16100142" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : Short-term and long-term effects of nasal intermittent positive pressure ventilation in patients with obesity-hypoventilation syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25915102" id="rid25" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>26 : Efficacy of Different Treatment Alternatives for Obesity Hypoventilation Syndrome. Pickwick Study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3516586" id="rid26" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>27 : Hypercapnia in the obstructive sleep apnea syndrome. A reevaluation of the "Pickwickian syndrome".</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18203817" id="rid27" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>28 : Randomised trial of CPAP vs bilevel support in the treatment of obesity hypoventilation syndrome without severe nocturnal desaturation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25308722" id="rid28" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>29 : Mortality in obesity-hypoventilation syndrome and prognostic risk factors.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12183486" id="rid29" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>30 : Postevent ventilation as a function of CO(2) load during respiratory events in obstructive sleep apnea.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12379556" id="rid30" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>31 : Hypercapnia and ventilatory periodicity in obstructive sleep apnea syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16384839" id="rid31" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>32 : Transition from acute to chronic hypercapnia in patients with periodic breathing: predictions from a computer model.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19452386" id="rid32" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>33 : Obesity hypoventilation syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/5129545" id="rid33" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>34 : Respiratory-renal adjustments in chronic hypercapnia in man. Extracellular bicarbonate concentration and the regulation of ventilation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10642388" id="rid34" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>35 : CO(2) homeostasis during periodic breathing in obstructive sleep apnea.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16774152" id="rid35" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>36 : Hypoxia impairs the arousal response to external resistive loading and airway occlusion during sleep.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10783935" id="rid36" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>37 : Prevalence and mechanisms of diurnal hypercapnia in a sample of morbidly obese subjects with obstructive sleep apnoea.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7991952" id="rid37" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>38 : Chronic hypercapnia in obstructive sleep apnea-hypopnea syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22212441" id="rid38" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>39 : Work of breathing and respiratory drive in obesity.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9493672" id="rid39" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>40 : Influence of noninvasive positive pressure ventilation on inspiratory muscle activity in obese subjects.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9493672" id="rid40" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>41 : Influence of noninvasive positive pressure ventilation on inspiratory muscle activity in obese subjects.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18552485" id="rid41" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>42 : Work of breathing in eucapnic and hypercapnic sleep apnea syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3942377" id="rid42" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>43 : Diaphragmatic responses to body position changes in obese patients with obstructive sleep apnea.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20005140" id="rid43" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>44 : Pleiotropic role of IGF-I in obesity hypoventilation syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20005140" id="rid44" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>45 : Pleiotropic role of IGF-I in obesity hypoventilation syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6812471" id="rid45" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>46 : Mass loading, sleep apnea, and the pathogenesis of obesity hypoventilation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17689236" id="rid46" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>47 : Prognostic value of mouth occlusion pressure in patients with chronic ventilatory failure.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26918192" id="rid47" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>48 : Correlates of obesity-related chronic ventilatory failure.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17218569" id="rid48" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>49 : Impaired objective daytime vigilance in obesity-hypoventilation syndrome: impact of noninvasive ventilation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1163544" id="rid49" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>50 : Decreased hypoxic ventilatory drive in the obesity-hypoventilation syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1163544" id="rid50" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>51 : Decreased hypoxic ventilatory drive in the obesity-hypoventilation syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1163544" id="rid51" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>52 : Decreased hypoxic ventilatory drive in the obesity-hypoventilation syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18053615" id="rid52" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>53 : Central leptin insufficiency syndrome: an interactive etiology for obesity, metabolic and neural diseases and for designing new therapeutic interventions.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9843551" id="rid53" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>54 : Leptin attenuates respiratory complications associated with the obese phenotype.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9843551" id="rid54" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>55 : Leptin attenuates respiratory complications associated with the obese phenotype.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30309268" id="rid55" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>56 : Intranasal Leptin Relieves Sleep-disordered Breathing in Mice with Diet-induced Obesity.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11809994" id="rid56" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>57 : Association of serum leptin with hypoventilation in human obesity.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17459895" id="rid57" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>58 : Hyperleptinaemia, respiratory drive and hypercapnic response in obese patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16179823" id="rid58" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>59 : Treatment of obesity hypoventilation syndrome and serum leptin.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21885724" id="rid59" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>60 : Noninvasive ventilation in mild obesity hypoventilation syndrome: a randomized controlled trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17189682" id="rid60" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>61 : Long-term non-invasive ventilation increases chemosensitivity and leptin in obesity-hypoventilation syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24828690" id="rid61" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>62 : Respiratory determinants of diurnal hypercapnia in obesity hypoventilation syndrome. What does weight have to do with it?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/4606399" id="rid62" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>63 : Current concepts in the pathogenesis of the obesity-hypoventilation syndrome. Mechanical and circulatory factors.</p>
</a>
</div>
</div>
</div>
</div>
</section>
</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->
<!-- End Footer Area -->
<!-- Back to top -->
<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->
<!-- Prpper JS -->
<!-- Bootstrap Min JS -->
<!-- Classy Nav Min Js -->
<!-- Owl Carousel Min Js -->
<!-- Magnific Popup JS -->
<!-- CounterUp JS -->
<!-- Waypoints JS -->
<!-- Form Validator Min JS -->
<!-- Contact Form Min JS -->
<!-- Main JS -->
<!-- Global site tag (gtag.js) - Google Analytics -->
</body>
</html>
